A new report shows there has been a sharp decline in Hepatitis A cases in recent years throughout the United States.

An analysis of federal data found that hospitalization rates from this disease have fallen from 7.2 to 2.9 patients per million admitted to hospitals from 2002 to 2011. Hepatitis A cases have fallen by almost 90% over the past 20 years, a major step forward in the fight against the potentially deadly liver disease.

The study was inconclusive on whether this decline was due to increased precautions in restaurants and other public places (where hepatitis A is commonly contracted) or due to the over 70% vaccination rate for Hepatitis A among children, but it is logical that both reasons were likely contributing factors. Another key indicator that may have played a role in the decline of Hepatitis A cases is the increased vaccination rates among travelers to countries where the disease remains endemic.

“Hepatitis A vaccination is very important for everyone, especially travelers to high risk countries,” says Melanie Kohr, Vice-President of Clinic Operations for Passport Health. “Travel trends are on the rise, and, if more people are vaccinated against this potentially deadly disease, then the likelihood of spreading it when a traveler returns greatly declines. This can play a critical role in national health in the long term and for the health of close family members, no matter the situation.”

Hepatitis A is an acute liver disease caused by the hepatitis A virus (HAV). It does not lead to chronic infection, according to the Centers for Disease Control. It is transmitted by the ingestion of contaminated food, fecal matter, or close person-to-person contact. The CDC estimates that more than 2,000 new cases happen every year and suggests vaccination for all children starting at age 1 year as well as travelers to certain high risk countries.

What other factors could play a role in this decline in hepatitis A infections? Please tell us your thoughts in a comment below.

Passport Health and the innovative ride-sharing service Uber have teamed up yet again to bring flu vaccine to UberHEALTH users free of charge – this time in Chicago. Protein Sciences Corporation, maker of the revolutionary flu vaccine – a latex-free, egg-free, and preservative-free flu vaccine – generously provided the vaccine for today’s event.

“When we heard about UberHEALTH, we knew this was a fresh approach to public health, and we wanted to play a role,” said Manon Cox, President and CEO of Protein Sciences Corporation. “We are thrilled to be able to take part in this creative partnership and bring flu vaccine to Uber users in Chicago.”

The vaccine is an exciting, new class of flu vaccine that is highly pure; it contains no egg protein, gelatin, thimerosal, latex, or influenza virus; and is manufactured in the United States using DNA and cell culture technology.

Like the first UberHEALTH events that took place last month in Boston and Washington, DC, Uber drivers will pair with registered Passport Health nurses to deliver no-cost flu vaccines and flu-prevention kits to UberHEALTH users in Chicago. The event runs today from 10 a.m. to 4 p.m. CST.

As flu season ramps up, finding ways to increase access to flu immunizations is a priority not just for Passport Health, but for public health advocates everywhere. The total economic impact of the flu is over $10 billion annually, the result of some 62 million flu cases and 226,000 hospitalizations in the United States each year.

Despite that, fewer than 40 percent of adults 18-64 years of age get their annual flu shot. In Illinois, just 35.7 percent of adults in that age range take the CDC’s recommendation to receive their yearly influenza immunization.

With fewer Americans seeking flu vaccines in a traditional setting, Passport Health knows that innovation is key to improving vaccination rates. That’s why Passport Health is excited to once again be working with UberHEALTH to bring flu prevention kits and flu vaccines directly to users.

For 20 years, Passport Health has provided its clients with protection against vaccine-preventable diseases, including the flu. This year, Passport Health launched FluFree.com, a website designed to address the growing gap between the need for vaccination and the number of people who actually chose to get vaccinated.

“People know they need to get their flu shot, but sometimes life gets in the way of taking care of your health,” said Fran Lessans, RN, MS, Founder, President and CEO of Passport Health. “That’s where partnerships like this one make such an impact. It’s hard to say no to a flu shot on demand!”

For more information on influenza, flu vaccines and flu safety, visit FluFree.com, or contact a Passport Health immunization specialist at 1-844-FLU-FREE.

A new study found that military personnel who were taught to give themselves nasal spray flu vaccinations had the same level of immunity as those who were given the vaccine by health professionals.

This is a huge step forward for MedImmune’s nasal spray vaccine, which is the preferred method of vaccination for most healthy kids aged two to eight years. However, don’t expect to be giving it to your own child anytime soon. The nasal spray may be (relatively) easy to administer, but there are still some risk factors involved.

“It’s a very interesting concept and I can definitely see some benefits” says Dr. Jonathan Temte who heads a panel that advises the CDC on vaccine policy. “Before anyone could endorse this in children, one would have to have an appropriately designed study that shows equal efficacy, equal safety, and then the acceptability.”

In this case, safety is key. Self-vaccination with nasal flu vaccine isn’t as easy as it sounds, and vaccinating children is more of a science than simply spraying something up their noses. While everyone over six months old should get a flu shot, according to the CDC, special vaccination guidelines apply to children when they receive their first vaccination, and medical history should always be reviewed before a vaccine is administered.

The nasal vaccine is also a little trickier to apply than a nasal spray you might be accustomed to using for allergies, for example. Health workers that administer the vaccine need to be sure that it has fully entered the nose and that children, and parents too, don’t squirt it out of their nose.

Whether self-vaccination will become something more common in the future is unknown due to regulatory guidelines and a lack of testing, and, as Dr. Temte put it, we are still a long way from anything definitive. However, the topic is certainly an interesting one.

So, we want to hear from you! Would you vaccinate yourself, or would you prefer the help of a professional? Feel free to leave a comment below and let us know what you would choose to do!

Sophie Blackall isn’t just the illustrator of the very popular “Ivy and Bean” series of children’s books, she is also a huge proponent of measles vaccination. As part of that effort, she is now working with the American Academy of Pediatrics to create engaging posters that feature her characters. The AAP hopes doctors will post these around their offices to make vaccination resonate with their young patients..

“We wanted to give doctors something that would speak to the kids, something funny and eye-catching that they can put up in the waiting room and that families can discuss,” said Blackall in an interview with NPR. “It sometimes gets lost in the whole noise about children’s health, but it’s so important.”

Measles is a highly contagious respiratory disease which causes fever, runny nose, cough, and a rash all over the body. About one out of 10 children with measles also gets an ear infection, and up to one out of 20 children who gets infected also gets pneumonia. For every 1,000 children who get measles, one to two will die. Indeed, measles is a serious matter, and children should be aware of this potential threat.

As Blackall points out, measles is an entirely preventable disease that can be avoided through basic vaccination and a focus on personal health.

Over the last year, the world has seen a resurgence in measles in areas that used to be relatively free of the disease, with outbreaks in the United States (Ohio) and the United Kingdom (Wales). The disease is still endemic to some less developed regions as well. Lack of vaccination is seen as a main cause for both the resurgence and persistence of the disease.

We would like to hear from you! What other children’s characters, or even adult characters, do you think could be useful in a campaign like this? Feel free to post them below in the comments or over on our Facebook page!

The word anthrax typically conjures up terrifying thoughts of a potentially deadly infection or a bioterrorist attack. Luckily, there is a vaccine to prevent anthrax. Although few commercial vendors stock this vaccine, it is available at Passport Health clinic locations nationwide. Interestingly, in the near future, a benefit may come from this deadly disease, as current research suggests that anthrax might be a means of killing cancer.

A team of researchers at the Massachusetts Institute of Technology has discovered that bacillus anthracis, the bacteria that can lead to a deadly anthrax infection, can be re-engineered as a delivery system for administering cancer-fighting drugs. In a paper released in ChemBioChem, the MIT researchers showed how a disarmed version of anthrax could deliver antibody drugs to the cells most in need in order to aid their fight against cancer.

“Anthrax toxin is a professional at delivering large enzymes into cells,” said Bradley Pentelute, a researcher on the project. “We wondered if we could render anthrax toxin nontoxic, and use it as a platform to deliver antibody drugs into cells.”

By removing the harmful sides of the anthrax bacteria, Pentelute and his team were able to create a delivery system that is far more efficient than what has been previously used in biotechnology.

While these findings are quite promising, there is still a lot of work that needs to be done on the project. The team is now trying to treat tumors in mice and is working on ways to deliver the antibody-carrying bacteria to specific types of cells.

“This work represents a prominent advance in the drug-delivery field,” said Jennifer Cochran, an associate professor of bioengineering at Stanford University. “Given the efficient protein delivery Pentelute and colleagues achieved with this technology compared to [others]…studies to translate these findings into in vivo disease models will be highly anticipated.”

The Anthrax vaccine has been licensed in the US since 1970, but this new finding is a promising step forward for cancer research and research related to the deadly bacteria.

For more information on anthrax, contact a Passport Health vaccine specialist either through our website or by calling 1-888-499-PASS (7277).